MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF wt metastatic colorectal cancer ☆
Title:
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF wt metastatic colorectal cancer ☆
Author:
Tabernero, J. Grothey, A. Arnold, D. de Gramont, A. Ducreux, M. O’Dwyer, P. Tahiri, A. Gilberg, F. Irahara, N. Schmoll, H.-J. Van Cutsem, E.